Predictive Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
DTC Audiences
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Television
Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.
Swoop Agents
Unlock your brand.com first-party data potential. Swoop’s award winning chatbot transforms site level engagement into valuable first-party data with conversational AI.
Swoop
At Swoop, we are dedicated to creating a culture of innovation, where employees are celebrated, supported, and encouraged to innovate from within.
Swoop
Honored by innovation awards from the BIG and PM360, Swoop’s predictive audiences showcase how pharmaceutical marketing can help improve patient’s health outcomes.
Television
Connecting with the right audiences with precision and impact across all channels allows pharmaceutical companies to enhance patient engagement and drive better health outcomes. In addition to helping patients by connecting them with new information, consumer ads positively influence healthcare providers (HCP) prescribing behavior.
DTC Marketing
In today’s complex healthcare marketing landscape, selecting the right Demand-Side Platform (DSP) is crucial for pharmaceutical brands aiming to deliver impactful, targeted, and compliant omnichannel campaigns to patients and healthcare providers (HCPs). This checklist will guide you through the essential factors to consider, ensuring that your chosen DSP aligns with your marketing objectives, respects patient […]
Research was undertaken to better understand awareness and experiences with biomarker testing among patients living with Non-Small Cell Lung Cancer (NSCLC). Additionally, research sought to understand potential health inequities in terms of access to biomarker testing.
